#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	20986	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2262	913.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1453	1453	C	1176	C,A	1124,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	20986	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2262	913.1	0	HET	.	.	.	C207T	.	207	207	C	476	476	C	1172	C,T	862,243	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	20986	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2262	913.1	0	HET	.	.	.	C451T	.	451	451	C	720	720	C	1185	C,T	586,555	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	39482	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3657	1066.0	0	.	n	.	0	T695C	SNP	695	695	T	1085	1085	C	1225	C	1183	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	39482	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3657	1066.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	2028	2028	G	1199	G,A	833,312	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	39482	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3657	1066.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2361	2361	C	1228	C	1169	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	39482	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3657	1066.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2435	2435	A	1247	A	1196	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	39482	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3657	1066.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2987	2987	C	1270	C	1225	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2484	folP	855	855	100.0	folP.l6.c17.ctg.1	1736	140.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1170	1172	AGC	225;225;227	A;G;C	218;214;219	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6778	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3368	198.3	1	SNP	p	S91F	1	.	.	271	273	TTC	584	586	TTC	236;235;234	T;T;C	226;225;222	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6778	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3368	198.3	1	SNP	p	G95N	0	.	.	283	285	GGC	596	598	GGC	227;228;224	G;G;C	212;214;212	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6778	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3368	198.3	1	SNP	p	D95G	1	.	.	283	285	GGC	596	598	GGC	227;228;224	G;G;C	212;214;212	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	2274	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1417	158.7	1	SNP	p	G45D	0	.	.	133	135	GGC	510	512	GGC	289;287;286	G;G;C	274;273;270	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1268	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1175	106.6	0	.	n	.	0	A197.	DEL	197	197	A	682	682	A	277	A	267	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6488	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2972	215.5	1	SNP	p	D86N	0	.	.	256	258	GAC	563	565	GAC	233;233;237	G;A;C	227;218;228	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6488	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2972	215.5	1	SNP	p	S87R	1	.	.	259	261	CGT	566	568	CGT	237;238;240	C;G;T	230;229;229	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6488	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2972	215.5	1	SNP	p	R87I	0	.	.	259	261	CGT	566	568	CGT	237;238;240	C;G;T	230;229;229	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6488	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2972	215.5	1	SNP	p	R87W	0	.	.	259	261	CGT	566	568	CGT	237;238;240	C;G;T	230;229;229	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6488	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2972	215.5	1	SNP	p	S88P	0	.	.	262	264	TCC	569	571	TCC	241;243;247	T;C;C	231;235;238	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5500	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2761	196.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1640	1642	GGC	285;281;280	G,T;G;C,A,G	272,1;267;263,1,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	5802	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2517	226.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1316	1318	GCC	335;335;339	GCC,GC;C;C	325,1;316;322	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5802	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2517	226.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1319	1321	ATG	337;337;332	A,T;T,C;G,A	319,1;318,1;313,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5802	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2517	226.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1331	1333	ACC	323;325;328	A;C;C	305;314;310	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5802	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2517	226.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1331	1333	ACC	323;325;328	A;C;C	305;314;310	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5802	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2517	226.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1832	1834	ACC	290;291;294	A;C;C	275;280;282	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5802	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2517	226.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1886	1888	GCG	262;264;265	G;C;G	252;254;254	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5802	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2517	226.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1886	1888	GCG	262;264;265	G;C;G	252;254;254	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5802	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2517	226.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2009	2011	GGT	230;226;226	G;G,T;T	221;217,1;214	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5802	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2517	226.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2018	2020	AGC	221;217;214	A;G;C	205;208;203	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5802	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2517	226.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2036	2038	CCG	172;175;173	C,G;C,G;G,T,C	147,10;150,2;146,1,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	8190	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3186	253.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1649	1651	CCG	293;295;297	C,G;C,T;G	267,2;276,1;269	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2960	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1708	170.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	530	530	C	223	C,A	211,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	394	porB1a	984	297	91.03	porB1a.l15.c30.ctg.2	405	34.5	0	.	p	.	0	H217N	NONSYN	649	651	CAT	128	130	AAT	28;27;28	A;A;T	28;27;28	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	394	porB1a	984	297	91.03	porB1a.l15.c30.ctg.2	405	34.5	0	.	p	.	0	D218N	NONSYN	652	654	GAT	131	133	AAT	28;29;29	A;A;T	28;29;29	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	394	porB1a	984	297	91.03	porB1a.l15.c30.ctg.2	405	34.5	0	.	p	.	0	V226A	NONSYN	676	678	GTA	155	157	GCA	30;30;30	G;C;A	29;30;30	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	394	porB1a	984	297	91.03	porB1a.l15.c30.ctg.2	405	34.5	0	.	p	.	0	.	MULTIPLE	700	702	ACT	178	180	GTA	29;29;29	G;T;A	29;28;29	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	394	porB1a	984	297	91.03	porB1a.l15.c30.ctg.2	405	34.5	0	.	p	.	0	N237fs	FSHIFT	709	709	A	187	187	A	28	A	28	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4202	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1607	256.6	0	.	p	.	0	G210R	NONSYN	628	630	GGA	938	940	AGA	363;363;365	A,G;G;A	350,1;344;352	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4202	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1607	256.6	0	.	p	.	0	S217G	NONSYN	649	651	AGT	959	961	GGT	343;341;349	G,A;G;T	330,2;333;336	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4202	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1607	256.6	1	SNP	p	G120K	1	.	.	358	360	AAG	668	670	AAG	342;338;342	A,C;A;G	323,1;323;323	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4202	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1607	256.6	1	SNP	p	A121N	1	.	.	361	363	AAC	671	673	AAC	345;346;341	A;A;C	329;332;325	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4202	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1607	256.6	1	SNP	p	N121D	0	.	.	361	363	AAC	671	673	AAC	345;346;341	A;A;C	329;332;325	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	14676	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4902	295.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1790	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	974	180.4	1	SNP	p	V57M	1	.	.	169	171	ATG	513	515	ATG	340;337;337	A;T;G	333;328;328	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
